ArticleJournal of medical case reports2025
A giant symptomatic primary ovarian leiomyoma with prominent necrosis and degenerative changes in a 75-year-old female: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Giant Primary Ovarian Leiomyoma Mimicking Ovarian Malignancy in an Elderly Postmenopausal Woman: A Rare Case Report.Clinical case reports · 2026Article
- When Benign Masquerades as Malignant: A Case of Expansively Growing Ovarian Leiomyoma Challenging Preoperative and Intraoperative Diagnosis.Clinical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdnexal masses represent a prevalent gynecological condition that may affect females of any age, although particularly those of reproductive age. These masses can be classified as either physiological or neoplastic, with the majority of adnexal neoplasms being benign. Primary ovarian leiomyoma is an exceedingly rare type of extrauterine leiomyomas, Its occurrence rate accounts for approximately 0.5-1% of all benign smooth muscle tumors found in the ovaries. These tumors are mostly asymptomatic, unilateral, non-malignant, often measuring less than 3 cm in size, and tend to be reported in women aged 20-65 years, with a considerably higher incidence in premenopausal women compared with postmenopausal women. These tumors lack distinguishing clinical features, thereby requiring comprehensive preoperative and postoperative investigations to avoid confusion with other differential diagnoses. CASE PRESENTATION: A 75-year-old gravida 5 para 5 Syrian female reported abdominal pain, heaviness, mild vaginal bleeding, and frequent urination. She had a history of well-controlled hypertension. Physical examination identified a large abdominopelvic mass, and subsequent imaging modalities demonstrated a 24 cm × 15.5 cm mass with notable cystic components. Following adequate preoperative assessment, a total hysterectomy and bilateral salpingo-oophorectomy were performed. Microscopic study of the resected mass revealed findings suggestive of primary ovarian leiomyoma with no cell atypia, and subsequent immunohistochemical staining corroborated the diagnosis. Mitotic activity was scant, thereby excluding malignancy, and the diagnosis of primary ovarian leiomyoma was established (please refer to the graphical abstract).
conclusionThis case highlights the importance of considering ovarian tumors in elderly females with a palpable abdominopelvic mass. Primary ovarian leiomyoma should not be excluded on the basis of the age of the patient. The definitive diagnosis remains dependent on postoperative histological evaluation. Leiomyosarcoma should be excluded in cases of large ovarian tumors, particularly in postmenopausal women, regardless of their benign features on microscopic examination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.